![Timothy J Schlidt](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Timothy J Schlidt
Oprichter bij Palo Santo Inc
Profiel
Timothy J Schlidt is the founder of Palo Santo Investors-Qp LP and Palo Santo Inc, which were both founded in 2020.
He is currently a Director at Reset Pharmaceuticals, Inc., a Vice President at Bridge Investments LLC, an Advisor at Tactogen, Inc., and a Board Member at Ksana Health, Inc. He previously worked as an Associate at Madison Dearborn Partners LLC from 2017 to 2019.
Mr. Schlidt received an undergraduate degree from the University of Wisconsin.
Actieve functies van Timothy J Schlidt
Bedrijven | Functie | Begin |
---|---|---|
Bridge Investments LLC
![]() Bridge Investments LLC Investment ManagersFinance Bridge Investments LLC (Bridge Investments) is a private equity and venture capital firm founded in 1998 by Robert Goldberg and Daniel Goldberg. The firm is headquartered in Chicago, Illinois. | Private Equity Investor | 01-05-2020 |
Palo Santo Inc
![]() Palo Santo Inc Investment ManagersFinance Palo Santo Inc (Palo Santo) is a venture capital firm founded in 2005 by Timothy J Schlidt and Daniel L. Goldberg. The firm is headquartered in New York. | Oprichter | 01-05-2020 |
Tactogen, Inc.
![]() Tactogen, Inc. Pharmaceuticals: MajorHealth Technology Tactogen, Inc. develops mental wellness medicines. The American company was founded in 2020 by Matthew Baggott and Luke A. Pustejovsky. Matthew Baggott has been the CEO since 2020. | Consultant / Adviseur | 01-12-2021 |
Ksana Health, Inc.
![]() Ksana Health, Inc. Packaged SoftwareTechnology Services Ksana Health, Inc. is a mental health technology company based in Eugene, OR. Ksana Health aims to transform mental health care and research by translating tools and findings developed by the University of S Center for Digital Mental Health into digital products and services. Led by Dr. Nick Allen, a professor of clinical psychology, the company provides clients, practitioners, administrators, and researchers with digital tools that continuously measure behavioral health and offer personalized interventions to improve mental health. The company was founded in 2019 by Will Shortt and Nick Allen, who has been the CEO since incorporation. | Directeur/Bestuurslid | 01-08-2022 |
Reset Pharmaceuticals, Inc.
![]() Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Directeur/Bestuurslid | 01-11-2021 |
Eerdere bekende functies van Timothy J Schlidt
Bedrijven | Functie | Einde |
---|---|---|
Madison Dearborn Partners LLC
![]() Madison Dearborn Partners LLC Investment ManagersFinance Madison Dearborn Partners LLC (Madison Dearborn Partners) is a private equity firm founded in 1992 by John A. Canning Jr., Paul J. Finnegan, Samuel M. Mencoff, Robin P. Selati, James N. Perry Jr. and Timothy P. Sullivan. The firm is headquartered in Chicago, Illinois. | Private Equity Analist | 01-08-2019 |
Palo Santo Investors-Qp LP | Oprichter | - |
Opleiding van Timothy J Schlidt
University of Wisconsin | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Madison Dearborn Partners LLC
![]() Madison Dearborn Partners LLC Investment ManagersFinance Madison Dearborn Partners LLC (Madison Dearborn Partners) is a private equity firm founded in 1992 by John A. Canning Jr., Paul J. Finnegan, Samuel M. Mencoff, Robin P. Selati, James N. Perry Jr. and Timothy P. Sullivan. The firm is headquartered in Chicago, Illinois. | Finance |
Bridge Investments LLC
![]() Bridge Investments LLC Investment ManagersFinance Bridge Investments LLC (Bridge Investments) is a private equity and venture capital firm founded in 1998 by Robert Goldberg and Daniel Goldberg. The firm is headquartered in Chicago, Illinois. | Finance |
Tactogen, Inc.
![]() Tactogen, Inc. Pharmaceuticals: MajorHealth Technology Tactogen, Inc. develops mental wellness medicines. The American company was founded in 2020 by Matthew Baggott and Luke A. Pustejovsky. Matthew Baggott has been the CEO since 2020. | Health Technology |
Ksana Health, Inc.
![]() Ksana Health, Inc. Packaged SoftwareTechnology Services Ksana Health, Inc. is a mental health technology company based in Eugene, OR. Ksana Health aims to transform mental health care and research by translating tools and findings developed by the University of S Center for Digital Mental Health into digital products and services. Led by Dr. Nick Allen, a professor of clinical psychology, the company provides clients, practitioners, administrators, and researchers with digital tools that continuously measure behavioral health and offer personalized interventions to improve mental health. The company was founded in 2019 by Will Shortt and Nick Allen, who has been the CEO since incorporation. | Technology Services |
Palo Santo Inc
![]() Palo Santo Inc Investment ManagersFinance Palo Santo Inc (Palo Santo) is a venture capital firm founded in 2005 by Timothy J Schlidt and Daniel L. Goldberg. The firm is headquartered in New York. | Finance |
Palo Santo Investors-Qp LP | |
Reset Pharmaceuticals, Inc.
![]() Reset Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reset Pharmaceuticals, Inc. is a clinical-stage biotechnology company that focuses on developing and commercializing novel treatments for patients suffering from mental illness related to life-altering diseases. Reset Pharmaceuticals is based in Great Neck, NY and was founded by Philip Taub and Jan-Anders Karlsson. The company's lead product candidate, the oral psilocybin, is being developed to treat demoralization syndrome in patients with cancer. Reset Pharma has a highly experienced team with a strong track record of successful development, approvals, and launches of neuroscience drugs. The company also has a scientific advisory board of key opinion leaders in psychiatry, oncology, and psychedelics, as well as a strategic advisory board of business leaders and financial experts. | Health Technology |